Article Text

Download PDFPDF
An amnesty for unpublished trials (Reprinted from the BMJ 1997;315: 622)
  1. Richard Smith, Editor, BMJ,
  2. Ian Roberts
  1. Editor, BMJ, Director, Child Health Monitoring Unit, Institute of Child Health, London WC1N 1EH

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

This month over 100 medical journals around the world are inviting readers to send information on unpublished trials. This amnesty should have important benefits for patients. Why?

Reports of properly conducted randomised controlled trials are the foundation of effective health care, but many are not submitted for publication.1 2 This reduces the power of systematic reviews to detect moderate but clinically important treatment effects. Patients may thus be denied effective forms of health care. A second problem is that since trials that show more promising effects are more likely to be submitted, research syntheses can give misleading conclusions about effectiveness. Patients may thus …

View Full Text